JP2009520875A - 新規の高安定性水溶液、該溶液を調製するためのナノコーティングを備えた電極、及びこの電極の製造方法 - Google Patents
新規の高安定性水溶液、該溶液を調製するためのナノコーティングを備えた電極、及びこの電極の製造方法 Download PDFInfo
- Publication number
- JP2009520875A JP2009520875A JP2008537073A JP2008537073A JP2009520875A JP 2009520875 A JP2009520875 A JP 2009520875A JP 2008537073 A JP2008537073 A JP 2008537073A JP 2008537073 A JP2008537073 A JP 2008537073A JP 2009520875 A JP2009520875 A JP 2009520875A
- Authority
- JP
- Japan
- Prior art keywords
- water
- acidic water
- electrolysis
- electrode
- excipients
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000243 solution Substances 0.000 title claims abstract description 49
- 239000007864 aqueous solution Substances 0.000 title claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 title description 8
- 239000002103 nanocoating Substances 0.000 title description 2
- 238000011282 treatment Methods 0.000 claims abstract description 31
- 239000012530 fluid Substances 0.000 claims abstract description 24
- 239000011248 coating agent Substances 0.000 claims abstract description 19
- 238000000576 coating method Methods 0.000 claims abstract description 19
- 239000007769 metal material Substances 0.000 claims abstract description 8
- 239000002105 nanoparticle Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 144
- 230000002378 acidificating effect Effects 0.000 claims description 55
- 239000000203 mixture Substances 0.000 claims description 53
- 238000005868 electrolysis reaction Methods 0.000 claims description 42
- 241001465754 Metazoa Species 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 30
- 210000003491 skin Anatomy 0.000 claims description 29
- 239000000843 powder Substances 0.000 claims description 23
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 19
- 239000012528 membrane Substances 0.000 claims description 18
- 229910052751 metal Inorganic materials 0.000 claims description 18
- 239000002184 metal Substances 0.000 claims description 18
- 210000001519 tissue Anatomy 0.000 claims description 17
- 239000000969 carrier Substances 0.000 claims description 15
- 230000000855 fungicidal effect Effects 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 13
- 229910001385 heavy metal Inorganic materials 0.000 claims description 12
- 239000002537 cosmetic Substances 0.000 claims description 11
- 239000010410 layer Substances 0.000 claims description 11
- 239000002245 particle Substances 0.000 claims description 11
- 230000000844 anti-bacterial effect Effects 0.000 claims description 10
- 239000000645 desinfectant Substances 0.000 claims description 10
- 230000003902 lesion Effects 0.000 claims description 10
- 239000002082 metal nanoparticle Substances 0.000 claims description 10
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 230000004054 inflammatory process Effects 0.000 claims description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 8
- 239000000417 fungicide Substances 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- 230000000249 desinfective effect Effects 0.000 claims description 7
- 238000005245 sintering Methods 0.000 claims description 7
- 210000004207 dermis Anatomy 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 230000010478 bone regeneration Effects 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 239000000654 additive Substances 0.000 claims description 4
- 208000010668 atopic eczema Diseases 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 4
- 239000003937 drug carrier Substances 0.000 claims description 4
- 230000003287 optical effect Effects 0.000 claims description 4
- 206010017533 Fungal infection Diseases 0.000 claims description 3
- 208000031888 Mycoses Diseases 0.000 claims description 3
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 3
- 208000036142 Viral infection Diseases 0.000 claims description 3
- 230000000172 allergic effect Effects 0.000 claims description 3
- 230000000507 anthelmentic effect Effects 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 210000002615 epidermis Anatomy 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 3
- 230000005415 magnetization Effects 0.000 claims description 3
- 239000002344 surface layer Substances 0.000 claims description 3
- 230000009385 viral infection Effects 0.000 claims description 3
- 208000035143 Bacterial infection Diseases 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
- 229910010293 ceramic material Inorganic materials 0.000 claims description 2
- 230000006806 disease prevention Effects 0.000 claims description 2
- 230000008105 immune reaction Effects 0.000 claims description 2
- 238000002513 implantation Methods 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- 239000000126 substance Substances 0.000 abstract description 7
- 239000002253 acid Substances 0.000 description 37
- 239000000047 product Substances 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 210000004379 membrane Anatomy 0.000 description 14
- 239000000523 sample Substances 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 241000282412 Homo Species 0.000 description 8
- 150000002739 metals Chemical class 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 206010061218 Inflammation Diseases 0.000 description 7
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 238000010790 dilution Methods 0.000 description 6
- 239000012895 dilution Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 239000008399 tap water Substances 0.000 description 5
- 235000020679 tap water Nutrition 0.000 description 5
- 238000012795 verification Methods 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 206010015943 Eye inflammation Diseases 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- QYSGYZVSCZSLHT-UHFFFAOYSA-N octafluoropropane Chemical compound FC(F)(F)C(F)(F)C(F)(F)F QYSGYZVSCZSLHT-UHFFFAOYSA-N 0.000 description 4
- 230000003204 osmotic effect Effects 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010015150 Erythema Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000013068 control sample Substances 0.000 description 3
- 230000001186 cumulative effect Effects 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 238000007654 immersion Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 230000003253 viricidal effect Effects 0.000 description 3
- 241000025053 Escherichia coli DSM 30083 = JCM 1649 = ATCC 11775 Species 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000001361 achilles tendon Anatomy 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000012223 aqueous fraction Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000001804 debridement Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 210000000744 eyelid Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229910002804 graphite Inorganic materials 0.000 description 2
- 239000010439 graphite Substances 0.000 description 2
- 239000008233 hard water Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 231100000053 low toxicity Toxicity 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 230000007903 penetration ability Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000013139 quantization Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 2
- 229960004306 sulfadiazine Drugs 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 229910052727 yttrium Inorganic materials 0.000 description 2
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108020000946 Bacterial DNA Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000344674 Enterococcus hirae ATCC 9790 Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- -1 NaCl Chemical class 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- 229910001260 Pt alloy Inorganic materials 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001420 bacteriolytic effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- NJDNXYGOVLYJHP-UHFFFAOYSA-L disodium;2-(3-oxido-6-oxoxanthen-9-yl)benzoate Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC([O-])=CC=C21 NJDNXYGOVLYJHP-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 201000004614 iritis Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000011858 nanopowder Substances 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000011045 prefiltration Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000005476 size effect Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000003330 sporicidal effect Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/46109—Electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/4618—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/467—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction
- C02F1/4672—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction by electrooxydation
- C02F1/4674—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis by electrochemical disinfection; by electrooxydation or by electroreduction by electrooxydation with halogen or compound of halogens, e.g. chlorine, bromine
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
- C25B11/00—Electrodes; Manufacture thereof not otherwise provided for
- C25B11/04—Electrodes; Manufacture thereof not otherwise provided for characterised by the material
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/04—Processes of manufacture in general
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/04—Processes of manufacture in general
- H01M4/0402—Methods of deposition of the material
- H01M4/0416—Methods of deposition of the material involving impregnation with a solution, dispersion, paste or dry powder
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/04—Processes of manufacture in general
- H01M4/0471—Processes of manufacture in general involving thermal treatment, e.g. firing, sintering, backing particulate active material, thermal decomposition, pyrolysis
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M4/00—Electrodes
- H01M4/02—Electrodes composed of, or comprising, active material
- H01M4/36—Selection of substances as active materials, active masses, active liquids
- H01M4/362—Composites
- H01M4/366—Composites as layered products
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/28—Treatment of water, waste water, or sewage by sorption
- C02F1/283—Treatment of water, waste water, or sewage by sorption using coal, charred products, or inorganic mixtures containing them
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
- C02F1/444—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by ultrafiltration or microfiltration
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/46109—Electrodes
- C02F1/46114—Electrodes in particulate form or with conductive and/or non conductive particles between them
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/48—Treatment of water, waste water, or sewage with magnetic or electric fields
- C02F1/488—Treatment of water, waste water, or sewage with magnetic or electric fields for separation of magnetic materials, e.g. magnetic flocculation
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/68—Treatment of water, waste water, or sewage by addition of specified substances, e.g. trace elements, for ameliorating potable water
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/46109—Electrodes
- C02F2001/46133—Electrodes characterised by the material
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/46109—Electrodes
- C02F2001/46133—Electrodes characterised by the material
- C02F2001/46138—Electrodes comprising a substrate and a coating
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/46109—Electrodes
- C02F2001/46133—Electrodes characterised by the material
- C02F2001/46138—Electrodes comprising a substrate and a coating
- C02F2001/46142—Catalytic coating
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/4618—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water
- C02F2001/46185—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water only anodic or acidic water, e.g. for oxidizing or sterilizing
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/46—Treatment of water, waste water, or sewage by electrochemical methods
- C02F1/461—Treatment of water, waste water, or sewage by electrochemical methods by electrolysis
- C02F1/46104—Devices therefor; Their operating or servicing
- C02F1/4618—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water
- C02F2001/46195—Devices therefor; Their operating or servicing for producing "ionised" acidic or basic water characterised by the oxidation reduction potential [ORP]
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2103/00—Nature of the water, waste water, sewage or sludge to be treated
- C02F2103/02—Non-contaminated water, e.g. for industrial water supply
- C02F2103/026—Treating water for medical or cosmetic purposes
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/46—Apparatus for electrochemical processes
- C02F2201/461—Electrolysis apparatus
- C02F2201/46105—Details relating to the electrolytic devices
- C02F2201/46115—Electrolytic cell with membranes or diaphragms
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2201/00—Apparatus for treatment of water, waste water or sewage
- C02F2201/46—Apparatus for electrochemical processes
- C02F2201/461—Electrolysis apparatus
- C02F2201/46105—Details relating to the electrolytic devices
- C02F2201/4612—Controlling or monitoring
- C02F2201/46125—Electrical variables
- C02F2201/4613—Inversing polarity
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2305/00—Use of specific compounds during water treatment
- C02F2305/08—Nanoparticles or nanotubes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/10—Energy storage using batteries
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/30—Hydrogen technology
- Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Electrochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Water Supply & Treatment (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Environmental & Geological Engineering (AREA)
- Hydrology & Water Resources (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Composite Materials (AREA)
- Manufacturing & Machinery (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Materials Engineering (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Toxicology (AREA)
- Metallurgy (AREA)
- Water Treatment By Electricity Or Magnetism (AREA)
- Electrodes For Compound Or Non-Metal Manufacture (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
i)ヒト又は動物向けの薬剤組成物を調製するための薬学的に受容可能である賦形剤及び担体、
ii)ヒト又は動物向けの化粧品組成物を調製するための化粧品用に受容可能である賦形剤及び担体、
iii)殺菌剤組成物を調製するのに食品分野で使用される賦形剤及び担体、及び
iv)駆虫又は防かび組成物を調製するため農業分野で使用される賦形剤及び担体、
からなる群から選択される1種以上の成分とを含む組成物によっても達成される。
(A1)上で定義されたとおりの金属のナノ粒子の1種以上の粉末を調製する工程、
(A2)少なくとも塗布すべき粉末の全てを溶解できるような量の、適切な溶媒中に、上記ナノ粒子の1種以上の粉末を溶解させ、1以上の溶液を得る工程、及び
(A3)前の工程で得た1以上の溶液を、好ましくは表面を不動態化された、金属プレート上で焼結させる工程、
を含む。
・工程(A1)の金属ナノ粒子の1種以上の粉末は、熱水化学処理によって有利に得られる、ZrO2、ZnO、Ru2O3、IrO2及びY2O3の粉末の組合せであり、ここで各粉末において粒子の少なくとも80重量%、より好ましくは少なくとも85%は60〜80nmの範囲の直径を有し、
・各粉末が溶解される工程(A2)の溶媒は、少なくとも塗布すべき全ての粉末を溶解できるような量の、30重量%塩酸水溶液であり、
・工程(A3)は、0.15〜0.35mmの範囲内の厚みをもち、その表面が不動態化されているTiO2プレートの両面で、工程(A2)から得た塩酸水溶液を焼結させるものであり、ここでの焼結は次の工程に従って行われる。
・水などの低導電率の流体の電解を加速するために従来用いられているNaClといった塩の消費量がより少ないという点で、より効率的な電解である。
・両方の電極が本発明による電極である非常に好ましい実施形態において、電極の極性を連続に変更する(「極性スワッピング」)ことが可能である。極性を急激に変更することにより、電解に付された流体中に存在する荷電粒子を、(粒子の電荷により及び電極の不変の正負符号により強いられる)一方向のみではなく、両方向に循環させることが可能であり、かくして電極のレベルで被着物が生成するのを回避してそれらの表面を清浄に保ちそれらの効率を最大レベルに保つのが可能になる。その上、電解槽内に半透性膜6を設けて2つのアノード及びカソード半チャンバを分割する場合、極性の変更は、前記膜の気孔の詰まりを回避し、装置の寿命を延ばす。
・ナノメートルコーティング5の存在は、上部電極による電荷の蓄積を従来の電極に比べ100%超にする。こうして、有意に高い電位で質的及び量的に異なる電解を行うことが可能になり、その結果、例えば、分子クラスタの大きさを小さくすることが可能になる。
・酸性及び塩基性の水画分においてその後発生するであろう電極自体の可溶化又はその表面への堆積物の発生を回避させる特徴である、非常に高いコンシステンシー、平滑さ及び表面密度が得られる。
・コーティング粒子のナノメートル寸法による量子効果(「ナノ効果」という用語でも文献中で知られている)を得ることが可能である。簡単に言うと、ナノメートル寸法に達した時点で、物質の光学的、磁気的及び電気的特性は根本的に変化する。いわゆるクラスタの標準的なナノメートル寸法が達成されるまで寸法を低減させることにより、前記クラスタ中に存在する原子の数の少なさ及びその低下した体積に起因して、電子構造においてエネルギーレベルの離散化(量子化)が明らかとなり、そしてこれはクラスタの大きさに依存し(この現象は「量子サイズ効果」として知られる)、また、通常の寸法の材料の特色を示すものとは対照的なものである全く新しい特性に依存する。
・半チャンバ7又は8の上部に配置され、電解すべき水をそこから入れる開口部(図中では参照番号により指示されていない)、及び
・半チャンバ7又は8の下部に配置され、結果として得られる酸性及び塩基性画分のための排出口として働くことができる付加的な開口部10及び11、
を通して装置1の外部に接続される。第2の開口部10及び11には、未分離の水が半チャンバから流出するのを防ぐようにされていて、且つ電解プロセスの終了時に開放されるようにされている閉鎖手段(図示せず)が設けられる。
・1組以上のフィルタ14、
・水を磁化するための1以上のユニット15、及び
・水に1種以上の任意成分を添加するための1以上のユニット16、
の中から選択された1以上の構成要素を含むことができる。
i)ヒト又は動物向けの薬剤組成物を調製するための薬学的に受容可能である賦形剤及び担体、
ii)ヒト又は動物向けの化粧品組成物を調製するための化粧品用に受容可能である賦形剤及び担体、
iii)殺菌剤組成物を調製するのに使用される賦形剤及び担体、及び
iv)駆虫又は防かび組成物を調製するための農業分野で使用される賦形剤及び担体、
を含む群から選択される1種以上の成分とを含む組成物に関する。
・食品用の殺菌剤組成物(食品分野)、
・環境、装置及び医療・手術器具向けの殺菌剤組成物、
・ヒト又は動物の再移植用組織向けの殺菌剤組成物、
・コンタクトレンズ及び光学機材全般をクリーニングし衛生維持するための殺菌剤組成物、
・家庭内の表面及び環境向けの殺菌剤組成物、
を調製するために一般に使用される成分を言うのに用いられる。
・表皮及び/又は真皮を侵す、炎症及び紅斑といったような、アレルギー性、炎症性及び免疫学的反応に結びつけられる皮膚反応現象。炎症の例としては、じんましん、皮膚炎(アレルギー性又は接触性)、湿疹、乾癬、白斑、及びふけなどがある。乾癬の治療については、本発明による酸性水の有効性はおそらく、それに含まれた活性塩素の剥脱効果に起因している。
・細菌及び/又は真菌及び/又はウイルス感染によってひき起こされる皮膚の表層又は深層の現象。
・火傷、日焼け及び床ずれといったような、皮膚及び/又は真皮の病変又は擦過傷。
この試料における重金属の濃度は、出願人の要請に基づき、認定された試験所で確認された。データを以下に提示する。
溶液259の試料
次に、経皮吸収に関連するパラメータとして対照試料(及びブランク)と比較した浸透濃度及び累積の浸透を計算して、マウスの皮膚での経皮吸収を評価する目的で、水259の試料を試験に付した。
方法及び材料: 試験試料: 溶液259、ビタミンEと5%で混合した無色透明な液体。
対照試料: 5%のビタミンEを含む従来のラテックス。
試験機器: 紫外線分光光度測定用UV−2100(島津製作所、日本)
試験対象動物: マウス(クンミン種)
数量: 2(雄:雌=50:50)
体重: 18〜22g
温度: 16〜21℃
相対湿度: 40〜60%
対象はグリセリンで希釈して1倍の希釈液を作った。
急性の皮膚の炎症と眼の炎症を査定して、溶液259の毒性を計算する。
方法及び材料: 試験対象試料: 未混合の溶液259、無色透明の液体。
試験対象動物: ウサギ(ニュージーランド種)
数量: 4(雄:雌=50:50)
体重: 2.5〜3.0kg、復旦大学実験動物部門により提供されたもの、証明書番号02−52−1
温度: 18〜22℃
相対湿度: 40〜70%
方法及び材料: 試験対象試料: 未混合の溶液259、無色透明の液体。
試験対象動物: ウサギ(ニュージーランド種)
数量: 4(雄:雌=50:50)
体重: 2.5〜3.0kg、復旦大学実験動物部門により提供されたもの、証明書番号02−52−1
温度: 18〜22℃
相対湿度: 40〜70%
溶液259の再生特性を試験する。
出願人の要請に基づき、認定試験所で溶液259の殺細菌力を試験した。データを下記の表に提示する。実験の詳細も同様に提供される。
・方法: 希釈・中和
・中和剤: 30g/リットルのポリソルベート80(Tween(登録商標)80)
・試験中に使用した製品の希釈剤: 硬水(300mg/kgのCaCO3)、無菌。
・製品の試験濃度: 100%、80%(v/v)。
・製品の希釈物の外観: 透明無色の溶液。
・接触時間: t=5分±10秒。
・試験温度: θ=20℃±1℃。
・妨害物質: 清浄な条件をシミュレートするための0.3g/リットルのウシアルブミン、汚れた条件をシミュレートするための3g/リットルのウシアルブミン。
・混合物(妨害物質と試験製品、希釈したもの、及びそのままのもの)の安定性: 試験全体を通して沈殿物なし。
・培養温度: 37℃±1℃。
溶液259の殺ウイルス力を、出願人が自社実験室で直接試験した。データを次の表に示す。
凍結乾燥した生体組織の水和: 溶液259と天然水を対比。この例に関係する写真は図3に含まれている。
T15’: 静的条件及び周囲温度で15分の浸漬後の組織フラグメント。
T45’: 静的条件及び周囲温度で45分の浸漬後の組織フラグメント。
特に緑膿菌に対する溶液259の抗菌特性を試験した。図4は、従来の酸性水(a)、溶液259(b)、及び生理溶液(c)で得られた、細菌壁の溶解を示す電子顕微鏡で撮影した写真である。写真5は、従来の酸性水(B)、溶液259(C)、及び生理溶液(D)で処置後の、緑膿菌DNAのゲル電気泳動の写真である。欄(A)は、基準として用いた重量スケールである。
Claims (28)
- 1種以上の金属のナノ粒子を含む表面コーティングを含むことを特徴とする、特に電解槽用の、電極。
- 金属材料、非金属材料、又はそれらの組合せから製作されたコアを含む、請求項1に記載の電極。
- 前記コーティングがZrO2、ZnO、Ru2O3、IrO2及びY2O3を含む、請求項1〜2のうちの1以上のものに記載の電極。
- 次に提示する順序で実施されるべき工程、すなわち、
(A1)1種以上の金属のナノ粒子の1種以上の粉末を調製する工程、
(A2)少なくとも塗布したい粉末の全てを溶解できるような量の、適切な溶媒中に、前記ナノ粒子の1種以上の粉末を溶解させ、1以上の溶液を得る工程、及び
(A3)前の工程で得た1以上の溶液を、電極のコアを形成することになる、好ましくは表面を不動態化された、金属プレート上で焼結させる工程、
によって前記電極のコーティングを作製する工程(A)を含む、請求項1〜3のうちの1以上のものに記載の電極を提供するための方法。 - 前記流体の電解処理のための少なくとも一つのチャンバ及び各チャンバに少なくとも1対ずつの電極を含み、前記電極が前記少なくとも一つのチャンバ内に配置されている装置、特に流体の電解処理のための装置であって、存在する電極のうちの少なくとも一つが請求項1〜3のうちの1以上のものに記載のものであることを特徴とする装置。
- 前記電解チャンバを2つの半チャンバに分割するようにされている膜を更に含み、当該膜が、金属ナノ粒子でコーティングされた開放気孔率を有するセラミック材料で作られていることを特徴とする、請求項6に記載の装置。
- 請求項6又は7に記載の装置を含むことを特徴とする、特に流体の電解処理のための、設備。
- 水の前処理手段、前記前処理手段の下流側に配置された水の電解処理手段、及び前記処理手段に前記前処理手段を接続するための流体回路を含み、前記電解処理手段が請求項6又は7に記載の装置を含む、請求項8に記載の設備。
- 請求項6又は7に記載の装置内で特定量の流体を電解に付す工程a)を含む、流体の電解を実施するための方法。
- 前記流体が水である、請求項10に記載の方法。
- ・ろ過、磁化及び添加剤添加のうちの1以上の工程を用いて、工程a)に付す前に前記水を前処理する工程a1)、及び
・電解により生成された酸性水と塩基性水の成分を分離する、工程a)に後続する工程b)、
を更に含む、請求項11に記載の方法。 - 請求項12に記載の電解方法で得られる、特に消毒剤としての、酸性水。
- 重金属を含まないことを特徴とする、請求項13に記載の酸性水。
- pHが3.0以下で0より高く、ORPが1000mV以上であり、10以下で1以上の分子クラスタを有することを更に特徴とする、請求項14に記載の酸性水。
- 最高90日間、光、空気及び熱から保護された状態に保った場合に安定していることを特徴とする、請求項13〜15のうちの1以上のものに記載の酸性水。
- 活性塩素を60mg/リットル未満の平均濃度で含むことを特徴とする、請求項13〜16のうちの1以上のものに記載の酸性水。
- 特に下地を消毒するための組成物であって、請求項13〜17のうちの1以上のものに記載の酸性水と、次のもの、すなわち、
i)薬学的に受容可能である賦形剤及び担体、
ii)化粧品用に受容可能である賦形剤及び担体、
iii)殺菌剤組成物を調製するのに使用される賦形剤及び担体、及び
iv)駆虫及び防かび組成物を調製するため農業分野で使用される賦形剤及び担体、
からなる群から選択される1種以上の成分とを含む組成物。 - 前記薬学的に受容可能な賦形剤及び担体が、局所殺菌剤組成物を調製するのに又は治療用の皮膚用組成物を調製するのに用いられる賦形剤及び担体である、請求項18に記載の組成物。
- 前記殺菌剤組成物のために使用される賦形剤及び担体が、
・食品用の殺菌剤組成物、
・環境、装置及び医療・手術器具向けの殺菌剤組成物、
・ヒト又は動物の再移植用組織向けの殺菌剤組成物、
・コンタクトレンズ及び光学機材全般をクリーニングし衛生維持するための殺菌剤組成物、
・家庭内の表面及び環境向けの殺菌剤組成物、
のための賦形剤及び担体からなる群から選択される、請求項18に記載の組成物。 - 請求項13〜17のうちの1以上のものに記載の酸性水と、それを下地に塗布するための手段とを含むキット。
- ヒト又は動物の体の皮膚の表層又は深層の疾患又は病変の治療及び予防用の薬剤を調製することへの、請求項13〜17のうちの1以上のものに記載の酸性水の使用。
- 前記皮膚の表層又は深層の疾患又は病変が、
・表皮及び/又は真皮を侵すアレルギー、炎症性又は免疫学的反応と結びつけられる皮膚現象、
・細菌及び/又は真菌感染及び/又はウイルス感染によりひき起こされる皮膚の表層又は深層の現象、及び
・皮膚及び/又は真皮の病変又は擦過傷、
の中から選択される、請求項22に記載の使用。 - 下地を消毒することへの、請求項13〜17のうちの1以上のものに記載の酸性水の使用。
- 前記下地が、1)無生物の表面及び物体、2)ヒト又は動物の体の表面、及び3)ヒト又は動物の体の分離された部分の表面、からなる群から選択される、請求項24に記載の使用。
- ヒト又は動物の体、又はその分離された部分の、美容上の処置のための、請求項13〜17のうちの1以上のものに記載の酸性水の使用。
- 骨の再生に適した製剤を搬送することへの、請求項13〜17のうちの1以上のものに記載の酸性水の使用。
- ヒト又は動物の脱水状態の再移植組織を再水和させることへの、請求項13〜17のうちの1以上のものに記載の酸性水の使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000079A ITPN20050079A1 (it) | 2005-10-28 | 2005-10-28 | Nuova soluzione acquosa ad alta stabilita' |
ITMI20061252 ITMI20061252A1 (it) | 2006-06-28 | 2006-06-28 | Nuova soluzione acquosa ad alta stabilita'. |
PCT/EP2006/067676 WO2007048772A1 (en) | 2005-10-28 | 2006-10-23 | New highly stable aqueous solution, electrode with nanocoating for preparing the solution and method for making this electrode |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009520875A true JP2009520875A (ja) | 2009-05-28 |
JP2009520875A5 JP2009520875A5 (ja) | 2010-02-04 |
Family
ID=37591887
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008537073A Pending JP2009520875A (ja) | 2005-10-28 | 2006-10-23 | 新規の高安定性水溶液、該溶液を調製するためのナノコーティングを備えた電極、及びこの電極の製造方法 |
Country Status (17)
Country | Link |
---|---|
US (1) | US8277634B2 (ja) |
EP (1) | EP1945576B8 (ja) |
JP (1) | JP2009520875A (ja) |
KR (1) | KR101321385B1 (ja) |
AU (1) | AU2006307923B2 (ja) |
BR (1) | BRPI0618007A2 (ja) |
CA (1) | CA2627083C (ja) |
CY (1) | CY1113512T1 (ja) |
DK (1) | DK1945576T3 (ja) |
ES (1) | ES2399444T3 (ja) |
IL (1) | IL190997A (ja) |
NZ (1) | NZ598070A (ja) |
PL (1) | PL1945576T3 (ja) |
PT (1) | PT1945576E (ja) |
RU (1) | RU2472713C2 (ja) |
SI (1) | SI1945576T1 (ja) |
WO (1) | WO2007048772A1 (ja) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8734421B2 (en) | 2003-06-30 | 2014-05-27 | Johnson & Johnson Consumer Companies, Inc. | Methods of treating pores on the skin with electricity |
NZ598070A (en) | 2005-10-28 | 2013-03-28 | Akuatech S R L | New highly stable aqueous solution, electrode with nanocoating for preparing the solution and method for making this electrode |
GB2442519A (en) * | 2006-10-02 | 2008-04-09 | Forum Bioscience Holdings Ltd | Wound treatment compositions |
CN101702880A (zh) * | 2007-04-25 | 2010-05-05 | 阿夸特克股份有限公司 | Nmr半峰宽减小的高度稳定电解水 |
WO2009065023A1 (en) * | 2007-11-14 | 2009-05-22 | Quos, Inc. | Multifunctional filtration and water purification systems |
ITMI20080114A1 (it) | 2008-01-25 | 2009-07-26 | Gian Battista Ceresa | Formulazioni topiche in forma di gel acquosi per il trattamento di dermatite atopica o come veicoli per la somministrazione transdermica di farmaci |
US20100072059A1 (en) * | 2008-09-25 | 2010-03-25 | Peters Michael J | Electrolytic System and Method for Enhanced Radiological, Nuclear, and Industrial Decontamination |
US20120089232A1 (en) | 2009-03-27 | 2012-04-12 | Jennifer Hagyoung Kang Choi | Medical devices with galvanic particulates |
EP2954901A1 (en) | 2009-06-17 | 2015-12-16 | APR Nanotechnologies S.A. | Methods of treating outer eye disorders using high orp acid water and compositions thereof |
WO2012150477A2 (en) * | 2010-12-16 | 2012-11-08 | Apr Nanotechnologies S.A. | Medical uses of nanoclustered water |
CN102826694B (zh) * | 2012-09-14 | 2013-09-18 | 西北有色金属研究院 | 一种膜分离/催化降解复合工艺处理工业污水的方法 |
ITMI20121965A1 (it) * | 2012-11-19 | 2014-05-20 | Lab Fitocosmesi & Farmaceuti Ci S R L | Composizione topica per il rilascio transepidermico o transdermico di paracetamolo |
BR112015015133A2 (pt) * | 2012-12-26 | 2017-07-11 | Koninklijke Philips Nv | dispositivo para preparar uma solução aquosa de eletrólito com ph ajustado |
US9234285B2 (en) | 2014-01-17 | 2016-01-12 | Brown University | Electrochemical processing of clathrate hydrates |
US10167209B2 (en) * | 2014-12-01 | 2019-01-01 | Drexel Univerisity | System and method for disinfection and fouling prevention in the treatment of water |
CN104591465B (zh) * | 2015-01-30 | 2017-04-05 | 深圳市危险废物处理站有限公司 | 一种线路板蚀刻废液回收行业含氨氮废水资源化利用和处理的方法 |
US10094030B2 (en) | 2015-02-03 | 2018-10-09 | Tipul Biotechnology, LLC | Devices and methods for electrolytic production of disinfectant solution from salt solution in a container |
CN107531520A (zh) * | 2015-04-14 | 2018-01-02 | 皇家飞利浦有限公司 | 具有再循环的电吸附净化系统 |
US20220241324A1 (en) | 2019-07-03 | 2022-08-04 | Apr Applied Pharma Research Sa | Therapeutic uses of oxidising hypotonic acid solutions |
US11655163B2 (en) * | 2020-05-19 | 2023-05-23 | Waterdiam Group Llc | Clean water for bathing and medical treatments |
CN112088875B (zh) * | 2020-09-28 | 2023-07-25 | 四川大学华西医院 | 一种溶液氧化还原电位可调的器官保存装置及其实现方法 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS558416A (en) * | 1978-07-01 | 1980-01-22 | Sumitomo Electric Ind Ltd | Production of electrode for water electrolysis |
JP2001087766A (ja) * | 1999-09-21 | 2001-04-03 | Nippon Intek Kk | 多機能電解水生成装置 |
JP2002317289A (ja) * | 2001-04-19 | 2002-10-31 | Asahi Kasei Corp | 水素発生用電極 |
JP2005029881A (ja) * | 2003-07-10 | 2005-02-03 | Mututry:Kk | 小型電解槽用電極構造 |
JP2005511280A (ja) * | 2001-12-05 | 2005-04-28 | オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド | 負および正の酸化還元電位(orp)水を生成するための方法および装置 |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1195871A (en) * | 1967-02-10 | 1970-06-24 | Chemnor Ag | Improvements in or relating to the Manufacture of Electrodes. |
US3616445A (en) * | 1967-12-14 | 1971-10-26 | Electronor Corp | Titanium or tantalum base electrodes with applied titanium or tantalum oxide face activated with noble metals or noble metal oxides |
IT978528B (it) * | 1973-01-26 | 1974-09-20 | Oronzio De Nora Impianti | Elettrodi metallici e procedimen to per la loro attivazione |
FR2237985A1 (en) * | 1973-07-20 | 1975-02-14 | Rhone Progil | Electrode for electrolysis cells - prepd. by coating a metal with a suspension of a perovskite cpd. in a cobalt salt soln. |
US4098669A (en) * | 1976-03-31 | 1978-07-04 | Diamond Shamrock Technologies S.A. | Novel yttrium oxide electrodes and their uses |
US4564434A (en) * | 1984-09-28 | 1986-01-14 | Busse Machukas Vladimir B | Electrode for electrolysis of solutions of electrolytes |
JPH0293088A (ja) * | 1988-09-29 | 1990-04-03 | Permelec Electrode Ltd | 水電解方法及び装置 |
US5711950A (en) * | 1990-01-12 | 1998-01-27 | Lorenzen; Lee H. | Process for preparing microclustered water |
US5622848A (en) * | 1990-05-23 | 1997-04-22 | Medical Discoveries, Inc. | Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood |
US5334383A (en) * | 1990-05-23 | 1994-08-02 | Medical Discoveries, Inc. | Electrically hydrolyzed salines as in vivo microbicides for treatment of cardiomyopathy and multiple sclerosis |
US5622828A (en) * | 1990-06-11 | 1997-04-22 | Nexstar Pharmaceuticals, Inc. | High-affinity oligonucleotide ligands to secretory phospholipase A2 (sPLA2) |
JP3442794B2 (ja) | 1991-01-17 | 2003-09-02 | 株式会社ソニー・クリエイティブプロダクツ | 化粧品 |
US5234563A (en) * | 1992-06-01 | 1993-08-10 | Janix Kabushiki Kaisha | Electrolytic ionized water producer of a continuous type |
JP3491286B2 (ja) | 1992-10-16 | 2004-01-26 | 大正製薬株式会社 | 平均的にクラスターの小さい水 |
DE69409996T2 (de) * | 1993-02-22 | 1999-01-14 | Nippon Intek Co., Ltd., Kawagoe, Saitama | Verfahren und Vorrichtung zur Erzeugung von elektrolytischem Wasser |
JP2652609B2 (ja) * | 1993-05-31 | 1997-09-10 | ミズ株式会社 | 電解水生成装置 |
US6207201B1 (en) * | 1993-06-03 | 2001-03-27 | Amuchina International, Inc. | Sodium hypochlorite based disinfectant and sterilizer for medical-surgical instruments |
RU2034791C1 (ru) * | 1993-06-21 | 1995-05-10 | Акционерное общество "КРОНТ-М ЛТД" | Установка для получения дезинфицирующего и моющего раствора |
JP3321256B2 (ja) * | 1993-07-30 | 2002-09-03 | ミズ株式会社 | 貯水式電解水生成装置 |
JPH07313980A (ja) * | 1994-05-27 | 1995-12-05 | Tdk Corp | イオン水生成装置用電極およびその製造方法ならびにイオン水生成装置 |
US5507932A (en) * | 1994-08-26 | 1996-04-16 | Schlumberger Technology Corporation | Apparatus for electrolyzing fluids |
JP3181796B2 (ja) * | 1994-10-28 | 2001-07-03 | 日本電気株式会社 | 電解水製造装置 |
JP3181795B2 (ja) * | 1994-10-28 | 2001-07-03 | オルガノ株式会社 | 電解水製造装置 |
JPH08192172A (ja) * | 1995-01-13 | 1996-07-30 | Taisho Pharmaceut Co Ltd | 小クラスター水 |
JPH08252310A (ja) * | 1995-01-17 | 1996-10-01 | Miura Denshi Kk | 電解生成酸性水を用いた人工透析装置の洗浄殺菌方法およびその装置 |
US5587058A (en) * | 1995-09-21 | 1996-12-24 | Karpov Institute Of Physical Chemicstry | Electrode and method of preparation thereof |
WO1997019707A1 (fr) | 1995-11-28 | 1997-06-05 | Ist Instant Surface Technology S.A. | Procede d'obtention d'agents liquides sterilisants et/ou stimulants et dispositif de mise en oeuvre du procede |
JP3785219B2 (ja) * | 1996-03-27 | 2006-06-14 | ペルメレック電極株式会社 | 酸性水及びアルカリ性水の製造方法 |
KR100504412B1 (ko) * | 1996-04-02 | 2005-11-08 | 페르메렉덴꾜꾸가부시끼가이샤 | 전해용전극및당해전극을사용하는전해조 |
JP3716042B2 (ja) * | 1996-04-24 | 2005-11-16 | ペルメレック電極株式会社 | 酸性水の製造方法及び電解槽 |
GB9620167D0 (en) | 1996-09-27 | 1996-11-13 | Enigma Uk Ltd | Electrochemical processing of liquid such as water |
WO1998017588A1 (fr) * | 1996-10-18 | 1998-04-30 | Miz Co., Ltd. | Eau electrolytique reductrice et procede de preparation de celle-ci |
RU2119802C1 (ru) * | 1996-12-18 | 1998-10-10 | Стерилокс Текнолоджиз, Инк. | Установка для электрохимической обработки жидкой среды (варианты) |
JPH10286571A (ja) * | 1997-04-16 | 1998-10-27 | Permelec Electrode Ltd | 酸性水及びアルカリ水製造用電解槽 |
JPH10314740A (ja) * | 1997-05-19 | 1998-12-02 | Permelec Electrode Ltd | 酸性水製造用電解槽 |
US6093292A (en) * | 1997-06-17 | 2000-07-25 | Shimadzu Corporation | Electrolyte producing apparatus with monitoring device |
JPH1135472A (ja) | 1997-07-22 | 1999-02-09 | Agaribi:Kk | 活性水およびその製造方法 |
US6294073B1 (en) * | 1997-10-22 | 2001-09-25 | Chemicoat & Co., Ltd. | Manufacturing method and apparatus of alkaline ionized water |
JP3783149B2 (ja) * | 1997-12-26 | 2006-06-07 | 株式会社オメガ | 電解装置 |
AU1325599A (en) | 1998-01-26 | 1999-08-12 | Hee Jung Kim | Electrolysis of water resulting in the reduction of fat content in the human liver |
US6126810A (en) * | 1998-04-27 | 2000-10-03 | Steris Corporation | Generation of active chlorine in the presence of an organic load from sodium chloride in water |
JP3859358B2 (ja) * | 1998-05-26 | 2006-12-20 | クロリンエンジニアズ株式会社 | 電解水製造装置 |
JP2000042556A (ja) * | 1998-05-28 | 2000-02-15 | Shimadzu Corp | 電解水製造装置 |
JP2000229815A (ja) | 1999-02-05 | 2000-08-22 | Toshimitsu Hattori | リポソームおよびその利用 |
DE19911746A1 (de) | 1999-03-16 | 2000-09-21 | Basf Ag | Diamantelektroden |
CA2315355C (en) | 1999-08-06 | 2011-12-20 | Sterilox Medical (Europe) Limited | Electrochemical treatment of an aqueous solution |
GB2355190B (en) * | 1999-08-23 | 2004-07-28 | Sterilox Medical | Improvements in or relating to sterilising preparations |
JP2001096272A (ja) | 1999-09-28 | 2001-04-10 | Japan Organo Co Ltd | 水の製造方法 |
JP2001139477A (ja) | 1999-11-17 | 2001-05-22 | Coherent Technology:Kk | 創傷部位の組織細胞増殖促進液 |
US20030185704A1 (en) * | 2000-01-12 | 2003-10-02 | Suzanne Bernard | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
US7393522B2 (en) * | 2000-01-12 | 2008-07-01 | Novabay Pharmaceuticals, Inc. | Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
US6426066B1 (en) * | 2000-01-12 | 2002-07-30 | California Pacific Labs, Inc. | Use of physiologically balanced, ionized, acidic solution in wound healing |
US20070051640A1 (en) * | 2000-08-07 | 2007-03-08 | Sterilox Technologies, Inc. | Electrochemical treatment of an aqueous solution |
US7291314B2 (en) * | 2001-12-20 | 2007-11-06 | Hydro Enterprises, Inc. | Activated water apparatus and methods |
JP4992003B2 (ja) * | 2000-12-27 | 2012-08-08 | 独立行政法人産業技術総合研究所 | 金属酸化物微粒子の製造方法 |
DE10134874B4 (de) * | 2001-07-18 | 2012-03-29 | Lantiq Deutschland Gmbh | Leitungstreiber |
JP5140218B2 (ja) * | 2001-09-14 | 2013-02-06 | 有限会社コヒーレントテクノロジー | 表面洗浄・表面処理に適した帯電アノード水の製造用電解槽及びその製造法、並びに使用方法 |
BRPI0117143B1 (pt) * | 2001-10-01 | 2015-07-14 | Aquilabs S A | Composição de ácido hipocloroso e suas aplicações |
NL1019105C2 (nl) * | 2001-10-03 | 2003-04-04 | Corus Technology B V | Werkwijze en inrichting voor het beheersen van het aandeel kristallen in een vloeistof-kristalmengsel. |
US6919005B2 (en) * | 2002-05-09 | 2005-07-19 | The United States Of America As Represented By The Secretary Of The Army | Configuration and electro-osmotic pulse (EOP) treatment for degrading porous material |
US20040055896A1 (en) * | 2002-09-20 | 2004-03-25 | Sterilox Technologies, Inc. | Biocidal solution |
GB2393737B (en) | 2002-10-03 | 2005-08-17 | Sterilox Tech Int Ltd | Electronic treatment of an aqueous salt solution |
WO2004078654A2 (en) | 2003-03-04 | 2004-09-16 | Frs Waterware, Inc. (D.B.A. Waterware, Inc.) | Free radical solution water |
US7566479B2 (en) * | 2003-06-23 | 2009-07-28 | Lg Chem, Ltd. | Method for the synthesis of surface-modified materials |
US20050067300A1 (en) * | 2003-09-25 | 2005-03-31 | The Procter & Gamble Company | Electrolysis device for treating a reservoir of water |
EP1701790B1 (en) * | 2003-10-29 | 2009-09-16 | Umicore AG & Co. KG | Precious metal oxide catalyst for water electrolysis |
JP5528657B2 (ja) | 2003-12-30 | 2014-06-25 | オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド | 酸化還元電位水溶液並びにその製造方法および使用方法 |
US20050196462A1 (en) * | 2003-12-30 | 2005-09-08 | Oculus Innovative Sciences, Inc. | Topical formulation containing oxidative reductive potential water solution and method for using same |
US20050139808A1 (en) * | 2003-12-30 | 2005-06-30 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and process for producing same |
US9168318B2 (en) * | 2003-12-30 | 2015-10-27 | Oculus Innovative Sciences, Inc. | Oxidative reductive potential water solution and methods of using the same |
DE102004026447B4 (de) | 2004-05-29 | 2009-09-10 | Verein für Kernverfahrenstechnik und Analytik Rossendorf e.V. | Verfahren und Vorrichtung zur Abtrennung von Sulfationen aus Wässern und zur Einbringung von Pufferkapazität in Wässer |
KR200367446Y1 (ko) * | 2004-06-12 | 2004-11-10 | (주)나노클러스터 | 귀금속 나노입자가 코팅된 탄소성 물질 및 그 제조방법 |
EP1863502B1 (en) * | 2005-03-23 | 2018-09-12 | Sonoma Pharmaceuticals, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
BRPI0610901B1 (pt) * | 2005-05-02 | 2019-04-16 | Oculus Innovative Sciences, Inc. | Uso de uma solução aquosa de potencial oxi-redutivo (orp). |
US20060249375A1 (en) * | 2005-05-06 | 2006-11-09 | Aoun Walid A | Electrochemical cell with elastomeric cap |
US20060275387A1 (en) * | 2005-06-03 | 2006-12-07 | BAGLEY David | Processed water and therapeutic uses thereof |
CA2623576A1 (en) * | 2005-09-21 | 2007-03-29 | Novabay Pharmaceuticals, Inc. | System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |
NZ598070A (en) | 2005-10-28 | 2013-03-28 | Akuatech S R L | New highly stable aqueous solution, electrode with nanocoating for preparing the solution and method for making this electrode |
JP5449780B2 (ja) * | 2006-01-20 | 2014-03-19 | オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド | 酸化還元電位水溶液を用いた炎症及び過敏症の治療又は予防方法 |
WO2008091032A1 (en) | 2007-01-25 | 2008-07-31 | Dong Yang Living Quest Co., Ltd. | Atopy eczema relaxant composition using natural material |
CN101702880A (zh) * | 2007-04-25 | 2010-05-05 | 阿夸特克股份有限公司 | Nmr半峰宽减小的高度稳定电解水 |
US8945630B2 (en) * | 2008-04-11 | 2015-02-03 | Aquilabs S.A. | Method of producing and applications of composition of hypochlorous acid |
EP2954901A1 (en) * | 2009-06-17 | 2015-12-16 | APR Nanotechnologies S.A. | Methods of treating outer eye disorders using high orp acid water and compositions thereof |
-
2006
- 2006-10-23 NZ NZ598070A patent/NZ598070A/xx unknown
- 2006-10-23 RU RU2008121255/05A patent/RU2472713C2/ru active
- 2006-10-23 DK DK06807483.0T patent/DK1945576T3/da active
- 2006-10-23 AU AU2006307923A patent/AU2006307923B2/en active Active
- 2006-10-23 SI SI200631505T patent/SI1945576T1/sl unknown
- 2006-10-23 JP JP2008537073A patent/JP2009520875A/ja active Pending
- 2006-10-23 KR KR1020087011231A patent/KR101321385B1/ko active IP Right Grant
- 2006-10-23 EP EP06807483A patent/EP1945576B8/en active Active
- 2006-10-23 US US12/091,765 patent/US8277634B2/en active Active
- 2006-10-23 PL PL06807483T patent/PL1945576T3/pl unknown
- 2006-10-23 WO PCT/EP2006/067676 patent/WO2007048772A1/en active Application Filing
- 2006-10-23 PT PT68074830T patent/PT1945576E/pt unknown
- 2006-10-23 BR BRPI0618007-8A patent/BRPI0618007A2/pt not_active Application Discontinuation
- 2006-10-23 CA CA2627083A patent/CA2627083C/en active Active
- 2006-10-23 ES ES06807483T patent/ES2399444T3/es active Active
-
2008
- 2008-04-27 IL IL190997A patent/IL190997A/en active IP Right Grant
-
2013
- 2013-01-07 CY CY20131100009T patent/CY1113512T1/el unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS558416A (en) * | 1978-07-01 | 1980-01-22 | Sumitomo Electric Ind Ltd | Production of electrode for water electrolysis |
JP2001087766A (ja) * | 1999-09-21 | 2001-04-03 | Nippon Intek Kk | 多機能電解水生成装置 |
JP2002317289A (ja) * | 2001-04-19 | 2002-10-31 | Asahi Kasei Corp | 水素発生用電極 |
JP2005511280A (ja) * | 2001-12-05 | 2005-04-28 | オキュラス イノヴェイティヴ サイエンシズ、インコーポレイテッド | 負および正の酸化還元電位(orp)水を生成するための方法および装置 |
JP2005029881A (ja) * | 2003-07-10 | 2005-02-03 | Mututry:Kk | 小型電解槽用電極構造 |
Also Published As
Publication number | Publication date |
---|---|
EP1945576B1 (en) | 2012-11-21 |
AU2006307923A1 (en) | 2007-05-03 |
CY1113512T1 (el) | 2016-06-22 |
US20080292717A1 (en) | 2008-11-27 |
US8277634B2 (en) | 2012-10-02 |
KR101321385B1 (ko) | 2013-10-30 |
NZ598070A (en) | 2013-03-28 |
IL190997A (en) | 2013-08-29 |
CA2627083C (en) | 2014-04-29 |
BRPI0618007A2 (pt) | 2011-08-16 |
PT1945576E (pt) | 2013-01-16 |
CA2627083A1 (en) | 2007-05-03 |
EP1945576B8 (en) | 2013-02-20 |
RU2008121255A (ru) | 2009-12-10 |
ES2399444T3 (es) | 2013-04-01 |
KR20080067649A (ko) | 2008-07-21 |
WO2007048772A1 (en) | 2007-05-03 |
RU2472713C2 (ru) | 2013-01-20 |
IL190997A0 (en) | 2008-12-29 |
AU2006307923B2 (en) | 2012-02-02 |
DK1945576T3 (da) | 2013-02-18 |
SI1945576T1 (sl) | 2013-02-28 |
PL1945576T3 (pl) | 2013-04-30 |
EP1945576A1 (en) | 2008-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2009520875A (ja) | 新規の高安定性水溶液、該溶液を調製するためのナノコーティングを備えた電極、及びこの電極の製造方法 | |
KR101500990B1 (ko) | Nmr 하프 선폭이 감소된 고 안정성 전해수 | |
JP2009520875A5 (ja) | ||
CN102758202B (zh) | 一种医用钛及钛合金表面抗菌涂层的制备方法 | |
US20160324891A1 (en) | Nanoclustered water having improved medical utility | |
WO2010146460A1 (en) | Methods of treating outer eye disorders using high orp acid water and compositions thereof | |
CN101346315B (zh) | 用于电解处理流体的设备,方法及该方法制备的酸性水 | |
US20080181919A1 (en) | Shiunko nanomicell for skin treatment and preparation method for the same | |
Simmons et al. | Application of carbon nanotubes to wound healing biotechnology | |
JP2002500055A (ja) | 根管用潅注媒体 | |
RU2264220C2 (ru) | Медно-серебряный ионатор и лечебное средство с антимикробным действием | |
MX2008005535A (en) | New highly stable aqueous solution, electrode with nanocoating for preparing the solution and method for making this electrode | |
ITMI20061252A1 (it) | Nuova soluzione acquosa ad alta stabilita'. | |
JP2001170644A (ja) | 電解生成清浄化水 | |
JP2006117611A (ja) | 遺体化粧メーキング剤及びその用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091022 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091211 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20100402 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111115 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20120214 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20120221 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120515 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20120612 |